Maurizio Bifulco Selected Research

Geranyltranstransferase

10/2017	Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.
3/2006	N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation.
1/2004	Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Bifulco Research Topics

Disease

72	Neoplasms (Cancer) 04/2022 - 06/2002
15	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 09/2003
12	Multiple Sclerosis 03/2022 - 03/2002
12	Colonic Neoplasms (Colon Cancer) 09/2019 - 01/2004
12	Breast Neoplasms (Breast Cancer) 05/2013 - 08/2002
10	Neoplasm Metastasis (Metastasis) 04/2021 - 05/2003
9	Obesity 02/2015 - 06/2007
7	Inflammation (Inflammations) 01/2021 - 02/2009
7	Nervous System Diseases (Neurological Disorders) 04/2017 - 05/2008
6	Pain (Aches) 03/2022 - 03/2002
6	Glioma (Gliomas) 01/2020 - 06/2015
5	Brain Neoplasms (Brain Tumor) 01/2019 - 10/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2013
4	Thyroid Neoplasms (Thyroid Cancer) 03/2014 - 09/2003
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2008 - 01/2004
3	Nausea 03/2022 - 04/2007
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2005
3	COVID-19 01/2021 - 11/2020
3	Carcinogenesis 10/2018 - 09/2009
3	Dermatitis 07/2017 - 01/2011
3	Coronary Disease (Coronary Heart Disease) 10/2014 - 05/2008
3	Substance-Related Disorders (Drug Abuse) 12/2010 - 06/2007
2	Vomiting 03/2022 - 04/2007
2	Anorexia 03/2022 - 08/2009
2	Virus Diseases (Viral Diseases) 03/2022 - 01/2021
2	Infections 01/2021 - 11/2020
2	Cystic Fibrosis (Mucoviscidosis) 04/2018 - 06/2011
2	Melanoma (Melanoma, Malignant) 01/2018 - 12/2014
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 10/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 10/2014
2	Stroke (Strokes) 01/2016 - 10/2014
2	Necrosis 09/2009 - 10/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Cancer Pain 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

28	EndocannabinoidsIBA 04/2021 - 03/2002
27	CannabinoidsIBA 03/2022 - 03/2002
17	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2015 - 08/2002
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2006
14	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 03/2002
13	anandamide (arachidonylethanolamide)IBA 05/2013 - 03/2002
12	RimonabantIBA 01/2017 - 10/2004
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2005
11	Mevalonic Acid (Mevalonate)IBA 11/2021 - 03/2009
9	EnzymesIBA 11/2021 - 08/2002
7	CholesterolIBA 01/2021 - 12/2005
7	LipidsIBA 01/2021 - 11/2005
7	Pharmaceutical PreparationsIBA 01/2020 - 11/2007
6	Terpenes (Terpenoids)IBA 04/2022 - 11/2006
5	Adenosine (Adenocard)FDA LinkGeneric 04/2022 - 11/2014
5	CateninsIBA 09/2021 - 11/2012
5	2-methylarachidonyl-2'-fluoroethylamideIBA 04/2010 - 09/2003
4	Biological ProductsIBA 01/2022 - 05/2008
4	Messenger RNA (mRNA)IBA 10/2017 - 01/2004
4	CB2 Cannabinoid ReceptorIBA 04/2017 - 01/2013
4	Lovastatin (Mevacor)FDA LinkGeneric 12/2013 - 11/2006
3	CannabidiolIBA 03/2022 - 09/2006
3	Dronabinol (THC)FDA LinkGeneric 03/2022 - 05/2003
3	NucleosidesIBA 01/2022 - 03/2009
3	LigandsIBA 01/2018 - 01/2012
3	GeranyltranstransferaseIBA 10/2017 - 01/2004
3	Croton OilIBA 07/2017 - 01/2011
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 01/2010
3	Therapeutic UsesIBA 03/2014 - 12/2005
3	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 03/2011 - 08/2002
3	2-methyl-2'-F-anandamideIBA 06/2010 - 05/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	farnesyl pyrophosphate (farnesyl diphosphate)IBA 11/2021 - 07/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 06/2010
2	Oncogene Proteins (Oncogene Protein)IBA 09/2019 - 09/2003
2	Fluorouracil (Carac)FDA LinkGeneric 09/2019 - 01/2016
2	TubulinIBA 01/2016 - 08/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2013 - 11/2005
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 02/2011 - 01/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2011 - 08/2002
2	Antineoplastic Agents (Antineoplastics)IBA 10/2010 - 11/2007
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 06/2010 - 05/2008
2	Estrogens (Estrogen)FDA Link 01/2008 - 12/2005
2	arvanilIBA 02/2006 - 03/2002
1	nabiximols (Sativex)IBA 03/2022
1	nabilone (Cesamet)FDA Link 03/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Positive Regulatory Domain I-Binding Factor 1IBA 11/2021
1	alpha-Crystallin B ChainIBA 05/2021
1	Small Heat-Shock ProteinsIBA 05/2021
1	AntigensIBA 01/2021
1	PlatinumIBA 01/2020
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	Ligases (Synthetase)IBA 09/2019

Therapy/Procedure

17	Therapeutics 01/2021 - 06/2002
6	Drug Therapy (Chemotherapy) 03/2022 - 09/2006
1	Radiotherapy 01/2022
1	Immunotherapy 01/2021